<table class="table table-bordered"> <tbody><tr> <td><h2><strong><span style="font-size: 16px;">ASNC is the international leader in <a href="https://www.asnc.org/education" title="ASNC Education">education</a>, <a href="https://www.asnc.org/advocacy" title="ASNC Advocacy">advocacy</a>, and <a href="https://www.asnc.org/guidelines">quality in cardiovascular imaging</a>, with over 4,000 members worldwide.</span></strong><br></h2><ul> <li>We provide our members with a variety of <strong><a href="https://www.asnc.org/onlinecme" title="Online CME">continuing medical education programs</a> </strong>related to nuclear cardiology and cardiovascular computed tomography (CT).</li> <li><strong>We promote accreditation and <a href="https://www.asnc.org/boardcertification">certification</a></strong> in nuclear cardiology.</li> <li><strong>We establish standards and <a href="https://www.asnc.org/guidelines" title="ASNC Guidelines">guidelines</a> for training and practice.</strong></li> <li>We serve as a representative in health policy and the <strong>principal <a href="https://www.asnc.org/advocacy" title="ASNC Advocacy">advocacy</a> voice</strong> for professionals in the field.</li> </ul><p><em>Founded in 1993 by a group of nuclear cardiology specialists who sensed the need for a professional society dedicated solely to the needs of those who perform these procedures. ASNC’s membership is composed of cardiologists, radiologists, physicians, scientists, technologists, imaging specialists, and other professionals dedicated to the science and practice of nuclear cardiology.</em></p></td> </tr> <tr> <td><table class="table table-bordered"> <tbody><tr> <td> <p><strong>Membership</strong></p> </td> <td> <p><a href="http://www.asnc.org/join">asnc.org/join</a> </p> </td> </tr> <tr><td><!--StartFragment--><strong>Donate to the IANC Research Fellowship Award</strong><!--EndFragment--></td><td><a href="https://www.asnc.org/donate">asnc.org/donate</a></td></tr><tr> <td> <p><strong>Guidelines</strong><br></p> </td> <td> <p><a href="http://www.asnc.org/guidelines">asnc.org/guidelines</a> </p> </td> </tr> <tr> <td> <p><strong>Webinars</strong></p> </td> <td> <p><a href="http://www.asnc.org/webinars">asnc.org/webinars</a> </p> </td> </tr> <tr> <td> <p><strong>ImageGuideRegistry</strong></p> </td> <td> <p><a href="https://imageguideregistry.org/">imageguideregistry.org</a></p> </td> </tr> <tr> <td> <p><strong>Board Prep</strong></p> </td> <td> <p><a href="www.asnc.org/boardprep">asnc.org/boardprep</a> </p> </td> </tr> <tr> <td> <p><strong>Cardiac Amyloidosis Resource Hub</strong></p> </td> <td> <p><a href="http://www.asnc.org/cardiacamyloidosis">asnc.org/amyloidosis</a> </p> </td> </tr> <tr> <td> <p><strong>Cardiac PET Resource Center</strong></p> </td> <td> <p><a href="http://www.asnc.org/PET">asnc.org/PET</a> </p> </td> </tr> <tr> <td> <p><strong>Trainee Education</strong></p> </td> <td> <p><a href="http://www.asnc.org/FITeducation">asnc.org/FITeducation</a> </p> </td> </tr> <tr> <td> <p><strong>Online CME/CE</strong></p> </td> <td> <p><a href="http://www.asnc.org/onlineCME">asnc.org/onlineCME</a> </p> </td> </tr> <tr> <td> <p><strong>Technologist Resource Center</strong></p> </td> <td> <p><a href="www.asnc.org/education_technologists">asnc.org/education_technologists</a> </p> </td> </tr><tr><td><!--StartFragment--><strong>Twitter</strong><!--EndFragment--></td><td><!--StartFragment--><a href="http://www.twitter.com/MyASNC" target="_blank">twitter.com/MyASNC</a><!--EndFragment--></td></tr><tr><td><!--StartFragment--><strong>LinkedIn</strong><!--EndFragment--></td><td><!--StartFragment--><a href="https://www.linkedin.com/company/american-society-of-nuclear-cardiology/?feedView=images&viewAsMember=true" target="_blank">Linkedin.com/ASNC</a><!--EndFragment--></td></tr> </tbody></table></td> </tr></tbody></table><p><br></p><p></p><p><br></p>

<p><strong><span style="font-size: 16px; color: rgb(149, 55, 52);">Get the ASNC Clinical and Quality Resources App now! </span></strong><br><!--EndFragment--></p><figure><iframe width="560" height="315" src="https://www.youtube.com/embed/c5KMwzpRxtg" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen=""></iframe></figure><p><strong><span style="color: rgb(149, 55, 52); font-size: 20px;"><br></span></strong></p><p><strong><span style="color: rgb(149, 55, 52); font-size: 20px;">How to Download</span></strong></p><p>From your phone:</p><ul><li><a href="https://apps.apple.com/us/app/id1507920008" target="_blank">App Store - ASNC Clinical & Quality Resources</a></li></ul><ul><li><a href="https://play.google.com/store/apps/details?id=org.asnc.guidelinesandstandards&hl=en" target="_blank">Google Play (Android) - ASNC Clinical & Quality Resources</a></li></ul><p>From your computer:</p><p><!--StartFragment--><em>To download, hover over the QR code with your camera.</em><!--EndFragment--></p><!--StartFragment--><figure><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/f56c8d2a56e4cbf0654ce604e7a33f68.png" data-image="mqxgou70tbny" class="img-responsive" alt="custom image" title="custom image" width="100" height="100" style="width: 100px; max-width: 100px; height: 100px;"></figure><p><!--StartFragment--><em></em><!--EndFragment--></p><!--EndFragment-->

<!--StartFragment--><!--StartFragment--><p>ASNC Nuclear Cardiology <strong>Board Exam Prep Course</strong></p><p>Whether you’re preparing for 2020 Nuclear Cardiology Board Exams or just want to stay current on board-focused updates in nuclear cardiology, the <a data-cke-saved-href="#VirtualFormat" href="https://secure007.membershipsoftware.org/asnc/console/sb_modify_page.asp?id=383#VirtualFormat">virtual</a> ASNC Board Exam Prep Course is for you. Learn from a renowned group of faculty who are experts in the field with content tailored to meet your study needs.<br></p><!--StartFragment-->Course materials and faculty-recorded lectures are available now, in advance of the virtual, live meeting October 17–18, 2020.<!--EndFragment--><br><br><p><strong>NEW for 2020:</strong><br></p><ul><li><strong>The virtual, live meeting will be held October 17-18, starting at 8am–11:30am ET</strong></li></ul><ul><li>Stream the self-paced virtual course materials and faculty-expert <a href="https://www.asnc.org/bp_program">video lectures</a> <strong>starting September 11, 2020</strong></li></ul><ul><li><strong>New hot topics</strong> include THREE 20-minute “Focused Topics”:</li></ul><ul><li>SPECT Viability</li></ul><ul><li>99mTcPYP imaging for Cardiac TTR Amyloidosis</li></ul><ul><li>Interpretation of cardiac and non-cardiac findings on SPECT and PET CT</li></ul><ul></ul><ul><li><strong>Interactive Q&A </strong>with faculty experts. </li></ul><ul><li>Downloadable PDFs of each speaker presentation, allowing participants to review all PDF slides before, during, and after the course. </li></ul><ul><li>Earn up to<strong> 21.75* <em>AMA PRA Category 1 Credits™</em></strong></li></ul><p>New Virtual Format</p><ul><li>ASNC’s 2020 <strong>Board Exam Prep Course</strong> is a virtual live meeting this year. Board Prep 2020 registrants will have up to 5 weeks, starting Sept 11, 2020, to review recorded lectures and take the self-paced mock exams associated with the lecture material, based on the CBNC blueprint. </li></ul><p><a href="https://www.asnc.org/blog_home.asp?Display=393"><strong>"With ASNC's New Virtual Board Prep Course, Learners Drive the Content"</strong></a></p><p>2020 Board Prep Meeting Agenda: <a href="https://www.asnc.org/bp_program">asnc.org/bp_program</a><br></p><p>Registration: <a href="https://www.asnc.org/bp_registration">asnc.org/bp_registration</a></p><!--EndFragment-->

<p><span style="font-size: 24px;"><strong><span style="color: rgb(128, 100, 162);">INDICATION</span></strong></span><span style="font-size: 16px;"><span style="font-size: 20px;"><strong><br></strong>Lexiscan is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.</span></span><strong><span style="color: rgb(128, 100, 162); font-size: 10px;"><br></span></strong></p><p><span style="font-size: 20px;"><span style="font-size: 24px;"><strong><span style="color: rgb(128, 100, 162);">IMPORTANT SAFETY INFORMATION<br></span></strong><strong><span style="color: rgb(128, 100, 162);">CONTRAINDICATIONS</span></strong></span></span><span style="font-size: 20px;"><br>Do not administer Lexiscan to patients with second- or third-degree AV block or sinus node dysfunction unless these patients have a functioning artificial pacemaker.</span><span style="font-size: 24px;"><br><strong></strong><strong><br></strong><strong>PLEASE SEE ADDITIONAL IMPORTANT SAFETY INFORMATION BELOW.<br></strong><strong>PLEASE SEE FULL </strong><strong><a href="https://www.astellas.us/docs/lexiscan.pdf?utm_source=branded_booth&utm_medium=website&utm_campaign=asnc_2020&utm_content=pi" target="_blank">PRESCRIBING INFORMATION</a></strong></span><strong><span style="font-size: 24px;"> FOR LEXISCAN.</span><br></strong><span style="font-size: 20px;"><strong><br></strong></span></p><p><span style="font-size: 20px;"><strong><span style="font-size: 24px;">Visit <a href="https://www.astellasmedinfo.com?utm_source=branded_booth&utm_medium=website&utm_campaign=asnc_2020&utm_content=info_form" target="_blank">Astellas Medical Information</a> to submit a Medical Information Request Form.</span></strong></span><span style="font-size: 24px;"><br><span style="color: rgb(128, 100, 162); font-size: 20px;"><strong><span style="font-size: 10px;"></span><br><br></strong></span><span style="color: rgb(128, 100, 162); font-size: 20px;"><span style="font-size: 10px;"></span></span></span><span style="text-align: justify; font-size: 20px; color: rgb(128, 100, 162);"><strong><strong style="color: rgb(128, 100, 162); font-size: 20px;"><span style="font-size: 24px;">Astellas Is Committed to Helping Support the Nuclear Cardiology Community During COVID-19 by Providing a Link to the ASNC, IAEA, and SNMMI Information Statement</span></strong><br></strong></span></p><a href="https://bit.ly/2EXDFkS" target="_blank"><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/788899f4fc37f7937b78aa8718ed9cb0.png" data-image="765te5w50kya" class="img-responsive center-block" alt="Download the COVID-19 Information Statement" title="custom image"></a><p><span style="text-align: justify; font-size: 20px; color: rgb(128, 100, 162);"><span style="font-size: 16px;"></span></span><span style="text-align: justify; font-size: 20px; color: rgb(128, 100, 162);"><span style="font-size: 14px;"><span style="font-size: 16px;"><span style="font-size: 18px;"><span style="color: rgb(0, 0, 0);">By clicking the link above, you are leaving the Lexiscan Virtual Booth. The document you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for its contents.</span></span></span></span><br></span></p><p><span style="text-align: justify; font-size: 20px; color: rgb(128, 100, 162);"><strong><br></strong></span></p><p><span style="text-align: justify; font-size: 24px; color: rgb(128, 100, 162);"><strong>SIMPLIFY THE STRESS^{®<span style="font-size: 16px;"><span style="font-size: 20px;"><br></span></span>}</strong></span><span style="font-size: 16px;"><span style="font-size: 20px;">Lexiscan can help simplify the pharmacologic stress process for MPI testing and help keep the nuclear lab running smoothly.¹</span></span><span style="font-size: 20px;"></span></p><p><br></p><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/b864bb96593cb8b5378f8b71e8f56752.png" data-image="fe799u24u7t7" class="img-responsive" alt="custom image" title="custom image"><p><strong><span style="color: rgb(128, 100, 162);"></span></strong></p><p><strong><strong><span style="color: rgb(128, 100, 162);"><span style="font-size: 16px;"><span style="font-size: 20px;">Lexiscan and tracer are administered in 1 minute.¹</span></span></span></strong></strong></p><p><span style="font-size: 20px;"><strong></strong></span></p><p><strong></strong></p><p><strong></strong></p><p></p><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/0383186fd87b570ea9017fc368c75f3b.png" data-image="me12vpp75sf5" class="img-responsive" alt="Lexiscan: 1-minute administration protocol" title="custom image"><p><span style="font-size: 14px;"><strong><span style="font-size: 10px;"></span></strong></span></p><p><span style="font-size: 24px; color: rgb(128, 100, 162);"><strong><strong><strong>SELECT SAFETY INFORMATION<span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="font-size: 20px;"><br></span></span></span></strong></strong></strong></span><span style="font-size: 16px;"><span style="font-size: 20px;"><strong><span style="color: rgb(128, 100, 162);"></span></strong>Adhere to the recommended duration of injection for Lexiscan. As noted in an animal study, longer injection times may increase the duration and magnitude of increase in coronary blood flow.</span></span></p><p></p><p></p><p><span style="font-size: 20px;"><strong><span style="color: rgb(128, 100, 162);"><span style="font-size: 24px;">IMPORTANT SAFETY INFORMATION (CONTINUED)<br><strong><span style="color: rgb(128, 100, 162);">WARNINGS AND PRECAUTIONS</span></strong></span></span></strong></span><span style="font-size: 16px;"><span style="font-size: 20px;"><strong><br>Myocardial Ischemia</strong><br>Fatal and nonfatal myocardial infarction, ventricular arrhythmias, and cardiac arrest have occurred following Lexiscan injection. Avoid use in patients with symptoms or signs of acute myocardial ischemia, for example unstable angina or cardiovascular instability; these patients may be at greater risk of serious cardiovascular reactions to Lexiscan. Cardiac resuscitation equipment and trained staff should be available before administering Lexiscan. Adhere to the recommended duration of injection. As noted in an animal study, longer injection times may increase the duration and magnitude of increase in coronary blood flow. If serious reactions to Lexiscan occur, consider the use of aminophylline, an adenosine antagonist, to shorten the duration of increased coronary blood flow induced by Lexiscan.</span></span></p><p><span style="font-size: 16px;"><span style="font-size: 20px;"><span style="font-size: 10px;"><br></span></span></span></p><p><span style="font-size: 24px;"><span style="font-size: 16px;"><span style="font-size: 20px;"><span style="font-size: 10px;"><strong></strong></span></span></span><span style="font-size: 20px;"><strong></strong></span></span></p><p><span style="font-size: 24px;"><strong>PLEASE SEE ADDITIONAL IMPORTANT SAFETY INFORMATION BELOW.<br></strong><strong>PLEASE SEE FULL </strong><strong><a href="https://www.astellas.us/docs/lexiscan.pdf?utm_source=branded_booth&utm_medium=website&utm_campaign=asnc_2020&utm_content=pi" target="_blank">PRESCRIBING INFORMATION</a></strong></span><strong><span style="font-size: 24px;"> FOR LEXISCAN.</span></strong></p><p><strong><span style="font-size: 20px;"></span></strong></p><p></p><p><strong><span style="font-size: 24px;"><span style="font-size: 20px;"></span></span></strong><br><span style="font-size: 20px;"></span><br></p><p></p><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/83724c83b8d3adf95b08b06309955c1e.png" data-image="gkpmx3m3kusr" class="img-responsive" alt="custom image" title="custom image"><p><strong><strong><span style="color: rgb(128, 100, 162);"></span></strong></strong></p><p><strong><strong><strong><span style="color: rgb(128, 100, 162);"><span style="font-size: 16px;"><span style="font-size: 20px;">Lexiscan is the only standard-dose, ready-to-use, pharmacologic stress agent in a prefilled syringe.^1,a</span></span></span></strong></strong></strong><br>^{<span style="font-size: 14px;"><span style="font-size: 12px;"><span style="font-size: 10px;"></span></span></span>}</p><figure><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/f5da56deb702bfd988b70e35c5e115c3.png" data-image="htt2s24rtpre" class="img-responsive" alt="SIMPLIFY THE STRESS®" title="custom image"></figure><p>^{<span style="font-size: 12px;"> <span style="font-size: 14px;"><span style="font-size: 16px;"><br></span></span></span>}<span style="font-size: 12px;"><span style="font-size: 14px;"><span style="font-size: 16px;">^aParenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not administer Lexiscan if it contains particulate matter or is discolored.</span></span><br></span></p><p><br></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/09c6edcc9711ea6fa49e82a4d1d81f73.png" data-image="nhlqmrhc7ms1" class="img-responsive" alt="custom image" title="custom image"><p><span style="color: rgb(128, 100, 162);"></span></p><p><strong><strong><strong><span style="color: rgb(128, 100, 162);"></span></strong></strong></strong></p><p><strong><strong><strong><strong><span style="color: rgb(128, 100, 162); font-size: 20px;">Lexiscan requires¹:</span></strong><span style="font-size: 20px;"><br></span></strong></strong></strong></p><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/a0c2817e40b14ab3e4e6ed7c6f5e9c40.png" data-image="b8t0vq7zdtnm" class="img-responsive" alt="Lexiscan requires Lexiscan requires NO weight-based dosing calculations, NO drawing up dose from vial, NO pump with timed drug infusion or special IV sets, NO infusion pump batteries or replacement costs, and NO disposable items2" title="custom image"><p><strong><strong><strong><strong><span style="color: rgb(128, 100, 162); font-size: 20px;"></span></strong></strong></strong></strong></p><p><span style="font-size: 20px;"><strong><span style="color: rgb(128, 100, 162);"></span></strong></span></p><p><span style="font-size: 20px;"><strong><span style="color: rgb(128, 100, 162);"><span style="font-size: 24px;">IMPORTANT SAFETY INFORMATION (CONTINUED)<br><strong><span style="color: rgb(128, 100, 162);">WARNINGS AND PRECAUTIONS</span></strong></span></span></strong><strong><span style="color: rgb(128, 100, 162);"><strong><span style="color: rgb(128, 100, 162);"></span></strong></span></strong></span><span style="font-size: 16px;"><span style="font-size: 20px;"><strong><br>Sinoatrial and Atrioventricular Nodal Block<br></strong><strong><strong></strong></strong>Adenosine receptor agonists, including Lexiscan, can depress the SA and AV nodes and may cause first-, second-, or third-degree AV block, or sinus bradycardia requiring intervention. In postmarketing experience, heart block (including third degree), and asystole within minutes of Lexiscan administration have occurred.</span></span></p><p></p><p><span style="font-size: 16px;"><span style="font-size: 20px;"><strong><strong><strong>Atrial Fibrillation/Atrial Flutter</strong><br></strong></strong>New-onset or recurrent atrial fibrillation with rapid ventricular response and atrial flutter have been reported following Lexiscan injection.</span></span></p><p><strong><span style="font-size: 24px;"><br></span></strong></p><p><span style="font-size: 24px;"><strong>PLEASE SEE ADDITIONAL IMPORTANT SAFETY INFORMATION BELOW.<br></strong><strong>PLEASE SEE FULL </strong><strong><a href="https://www.astellas.us/docs/lexiscan.pdf?utm_source=branded_booth&utm_medium=website&utm_campaign=asnc_2020&utm_content=pi" target="_blank">PRESCRIBING INFORMATION</a></strong><strong> FOR LEXISCAN.</strong></span><span style="font-size: 24px;"><br><br><br><span style="font-size: 24px;"><strong><span style="color: rgb(128, 100, 162);">Watch the Dosing and Administration Video</span></strong></span></span></p><p></p><div class="embed-responsive embed-responsive-16by9"><figure><iframe src="https://player.vimeo.com/video/454018981" style="border: 7px solid #702f8a;" frameborder="0" allow=" fullscreen" allowfullscreen="yes" class="embed-responsive-item" scrolling="no"></iframe></figure></div><p><br></p><p></p><p><strong><span style="font-size: 20px; color: rgb(128, 100, 162);"></span></strong></p><p><span style="font-size: 24px;"><strong><span style="font-size: 20px; color: rgb(128, 100, 162);"><br></span></strong><strong><span style="font-size: 24px; color: rgb(128, 100, 162);"><br></span></strong></span></p><p><span style="font-size: 24px;"><strong><span style="font-size: 24px; color: rgb(128, 100, 162);">Learn More About How Lexiscan Administration Can Help Support Your Nuclear Lab</span></strong></span><br></p><a href="https://lexiscan.com?utm_source=branded_booth&utm_medium=website&utm_campaign=asnc_2020&utm_content=visit_button" target="_blank"><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/cdedd417efe217eed666599cbc69df7c.png" data-image="yhy2otcyxf8s" class="img-responsive center-block" alt="Visit Lexiscan.com" title="custom image"></a><p><span style="font-size: 24px;"><span style="font-size: 20px;"><span style="color: rgb(128, 100, 162);"><strong><span style="font-size: 20px; color: rgb(128, 100, 162);"></span></strong></span></span><strong style="color: rgb(128, 100, 162); font-size: 20px;"><br></strong><br><span style="font-size: 20px;"><span style="color: rgb(128, 100, 162);"><strong><br></strong></span></span><span style="font-size: 24px; color: rgb(128, 100, 162);"><strong>Download Digital Resources to Help Patients Prepare for a Nuclear Stress Test</strong></span></span></p><a href="https://lexiscan.com/Resources/PatientResources?utm_source=branded_booth&utm_medium=website&utm_campaign=asnc_2020&utm_content=patient_guide" target="_blank"><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/fae18cdff75ca7a1ac961346cf7af9f2.png" data-image="pod22ybxrm4n" class="img-responsive center-block" alt="Explore Educational Resources for Your Patients" title="custom image"></a><p></p><p><span style="font-size: 20px;"><br></span></p><p><span style="color: rgb(128, 100, 162);"><strong><em><span style="font-size: 20px;"><span style="font-size: 24px;">Find more Lexiscan resources that support the nuclear lab. Click on Resources at the top of this page.</span></span></em></strong></span><br></p><p><span style="color: rgb(128, 100, 162);"><strong><em><br></em></strong></span></p><p><span style="color: rgb(128, 100, 162);"><strong><em><span style="font-size: 24px;"><br></span></em></strong></span><span style="color: rgb(128, 100, 162);"><strong><span style="color: rgb(128, 100, 162);"><span style="font-size: 24px;">IMPORTANT SAFETY INFORMATION (CONTINUED)<br><strong><span style="color: rgb(128, 100, 162);">WARNINGS AND PRECAUTIONS</span></strong></span></span></strong><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="font-size: 20px;"><strong><br></strong><strong>Hypersensitivity, Including Anaphylaxis</strong><strong><br></strong>Anaphylaxis, angioedema, cardiac or respiratory arrest, respiratory distress, decreased oxygen saturation, hypotension, throat tightness, urticaria and rashes have occurred. In clinical trials, hypersensitivity reactions were reported in fewer than 1 percent of patients.</span></span></span></span><strong><span style="font-size: 16px;"><span style="font-size: 20px;"><br></span></span></strong></p><p><span style="font-size: 16px;"><span style="font-size: 20px;"><strong>Hypotension</strong><br>Adenosine receptor agonists, including Lexiscan, induce arterial vasodilation and hypotension. The risk of serious hypotension may be higher in patients with autonomic dysfunction, hypovolemia, left main coronary artery stenosis, stenotic valvular heart disease, pericarditis or pericardial effusions, or stenotic carotid artery disease with cerebrovascular insufficiency. In postmarketing experience, transient ischemic attacks, seizures and syncope have been observed.</span></span></p><p><span style="font-size: 16px;"><span style="font-size: 20px;"><strong>Hypertension</strong><br>Adenosine receptor agonists, including Lexiscan, may result in clinically significant increases in blood pressure in some patients. In postmarketing experience, cases of potentially clinically significant hypertension have been reported, particularly in patients with underlying hypertension and when low-level exercise was included in the MPI.</span></span></p><p><span style="font-size: 16px;"><span style="font-size: 20px;"><strong>Bronchoconstriction</strong><br>Adenosine receptor agonists, including Lexiscan, may cause dyspnea, bronchoconstriction and respiratory compromise. Appropriate bronchodilator therapy and resuscitative measures should be available prior to and following Lexiscan administration.</span></span></p><p><span style="font-size: 16px;"><span style="font-size: 20px;"><strong>Seizure</strong><br>Lexiscan may lower the seizure threshold; obtain a seizure history. New-onset or recurrence of convulsive seizures has occurred following Lexiscan injection. Some seizures are prolonged and require emergent anticonvulsive management. Aminophylline may increase the risk of seizures associated with Lexiscan injection. Methylxanthine use is not recommended in patients who experience a seizure in association with Lexiscan administration.</span></span></p><p><span style="font-size: 16px;"><span style="font-size: 20px;"><strong>Cerebrovascular Accident (Stroke)</strong><br>Hemorrhagic and ischemic cerebrovascular accidents have occurred. Hemodynamic effects of Lexiscan including hypotension or hypertension may be associated with these adverse reactions.</span></span></p><p><span style="font-size: 24px;"><span style="color: rgb(128, 100, 162); font-size: 24px;"><strong>ADVERSE REACTIONS</strong></span><strong><span style="color: rgb(128, 100, 162);"><strong><span style="font-size: 16px;"><span style="font-size: 20px;"><span style="color: rgb(128, 100, 162);"></span></span></span></strong></span></strong></span><span style="font-size: 16px;"><span style="font-size: 20px;"><strong><br></strong>In clinical trials, the most common adverse reactions (≥5%) to Lexiscan were dyspnea, headache, flushing, chest discomfort, angina pectoris or ST-segment depression, dizziness, chest pain, nausea, abdominal discomfort, dysgeusia, and feeling hot. Most adverse reactions began soon after dosing, and generally resolved within approximately 15 minutes, except for headache, which resolved in most patients within 30 minutes. Aminophylline was used as a reversal agent in 3% of patients.</span></span></p><p><span style="font-size: 16px;"><span style="font-size: 20px;">In postmarketing experience, the following additional adverse reactions have occurred: supraventricular tachyarrhythmias, acute coronary syndrome (ACS), tremor, QTc prolongation, abdominal pain in association with nausea, vomiting, or myalgias, diarrhea, fecal incontinence, wheezing and musculoskeletal pain.</span></span></p><p><span style="font-size: 20px;"><strong></strong></span></p><p><span style="font-size: 20px;"><strong><br></strong></span></p><p><span style="font-size: 24px;"><strong>PLEASE SEE ADDITIONAL IMPORTANT SAFETY INFORMATION ABOVE.<br></strong><strong>PLEASE SEE FULL </strong><strong><a href="https://www.astellas.us/docs/lexiscan.pdf?utm_source=branded_booth&utm_medium=website&utm_campaign=asnc_2020&utm_content=pi" target="_blank">PRESCRIBING INFORMATION</a></strong><strong> FOR LEXISCAN.</strong></span></p><p><strong><br></strong></p><p><strong><span style="font-size: 20px;"></span></strong><strong></strong><span style="font-size: 12px;"><strong>REFERENCES: 1.</strong> Lexiscan [package insert]. Northbrook, IL: Astellas Pharma US, Inc. <strong>2.</strong> Astellas. Lexiscan. Data on File. <strong>3.</strong> Adenosine [package insert]. Rockford, IL: Mylan Institutional LLC. <strong>4.</strong> Dipyridamole [package insert]. Lake Forest, IL: Hospira, Inc.</span></p><p><span style="font-size: 12px;"><br></span></p><a href="https://www.astellas.com/us/" target="_blank"><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/35571b6cf6630948c406e92f1d37e907.png" data-image="q9jw53rfu23n" class="img-responsive" alt="Astellas is proud to be the elite sponsor of ASNC2020" title="custom image"></a><p><span style="font-size: 12px;"><br>Lexiscan^® and SIMPLIFY THE STRESS^® are registered trademarks of Astellas US LLC. Astellas^® and the flying star logo are registered trademarks of Astellas Pharma Inc.<br>Lexiscan was developed in collaboration with Gilead Palo Alto, Inc. (formerly CV Therapeutics, Inc.).<br>©2020 Astellas Pharma US, Inc.   All rights reserved.   012-1552-PM   9/20</span><span style="font-size: 12px;"><br></span></p>

<p> <strong><span style="color: rgb(255, 0, 0); font-size: 20px;">Discover Digital, Customizable Resources to Help Patients Understand What to Expect Before They Step Inside the Nuclear Lab </span></strong></p><div class="embed-responsive embed-responsive-16by9"><figure><iframe src="https://player.vimeo.com/video/454017519" frameborder="0" allow=" fullscreen" allowfullscreen="yes" class="embed-responsive-item" scrolling="no"></iframe></figure></div><p><strong><span style="font-size: 10px;"></span><br></strong><br><br>During a time when the healthcare landscape is shifting, it’s never been more important to bring together healthcare professionals and care teams all across the patient journey for the common goal of delivering quality, patient-centered care.</p><p></p><p></p><p><strong><span style="color: rgb(255, 0, 0);"><span style="font-size: 20px;">All Together. All For One. </span></span></strong></p><p>Our patient resources, which are available in multiple languages, are designed to support the nuclear lab and help patients prepare for their upcoming stress test. Resources include: </p><ul><li><strong>Patient Heart Imaging Test Guide</strong>—An educational patient brochure that explains what to expect and how to prepare for an upcoming nuclear stress test </li></ul><ul><li><strong>Patient Test Prep Checklist</strong>—A 2-page resource that can help patients prepare for their stress test, which includes a partial list of things your patients should not eat or drink prior to their test, as well as some medications to avoid </li></ul><ul><li><strong>Stress Test Coach Handout</strong>—A handout that lets patients know about the online resource, StressTestCoach.com, and prompts them to visit the site to join. StressTestCoach.com is designed to help prepare patients who are undergoing a nuclear stress test </li></ul><p>We at Astellas are committed to helping support your nuclear lab throughout this time. We encourage you to explore the <a href="https://allforonecardiovascular.com/cardiac-imaging-resources/patientresources?utm_source=nonbranded_booth&utm_medium=website&utm_campaign=asnc_2020&utm_content=afoc_resources page" target="_blank">other resources that we have to offer</a>, including educational resources for your colleagues and your referring and ordering providers. <strong><br></strong><br></p><p></p><a href="https://allforonecardiovascular.com/?utm_source=nonbranded_booth&utm_medium=website&utm_campaign=asnc_2020&utm_content=afoc_homepage" target="_blank"><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/c5aa91bfa9e3ce7861e0447e228d5cfc.png" data-image="6z2dlfbi0xog" class="img-responsive center-block" alt="Visit All For One Cardiovascular Today" title="custom image"></a><p><em><span style="font-size: 20px;"><span style="color: rgb(255, 0, 0);"><strong><span style="font-size: 16px;"><span style="font-size: 11px;"><br></span></span></strong></span></span></em><span style="font-size: 20px;"><span style="color: rgb(255, 0, 0);"> <span style="font-size: 20px;"><span style="color: rgb(255, 0, 0);"><em><strong>To directly access resources like these to help support the nuclear lab, click on Resources at the top of this page. </strong></em></span></span><br></span></span><span style="color: rgb(255, 0, 0);"><em><strong><span style="font-size: 10px;"></span><br><br></strong></em></span><span style="color: rgb(255, 0, 0);"><em><strong><span style="font-size: 10px;"></span><br></strong></em></span></p><a href="https://www.astellas.com/us/" target="_blank"><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/7366f5f7b3c16b7141d46228ef680591.png" data-image="wstn8r100q07" class="img-responsive" alt="Astellas is proud to be the elite sponsor of ASNC 2020" title="custom image" width="155" height="43" style="width: 155px; max-width: 155px; height: 43px;"></a><p><span style="color: rgb(0, 0, 0);"><br><span style="font-size: 11px;"> Astellas^®and the flying star logo are registered trademarks of Astellas Pharma Inc.<br></span></span><span style="color: rgb(0, 0, 0);"><span style="font-size: 11px;">©2020 Astellas Pharma US, Inc.   All rights reserved.   014-0405-PM   9/20</span></span><br><br></p>

<div class="embed-responsive embed-responsive-16by9"><div class="embed-responsive embed-responsive-16by9 embed-responsive-item" allowfullscreen="yes" scrolling="no"><p><strong>Pfizer Inc.: Breakthroughs that change patients’ lives</strong></p><p>At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at <a href="https://nam01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcts.businesswire.com%2Fct%2FCT%3Fid%3Dsmartlink%26url%3Dhttp%253A%252F%252Fwww.pfizer.com%26esheet%3D52050497%26newsitemid%3D20190802005497%26lan%3Den-US%26anchor%3Dwww.pfizer.com%26index%3D4%26md5%3D3fa542ac15375f69f13286275e3e7339&data=02%7C01%7CTNigro%40ges.com%7C5f02348056af4fd247d808d849f0120f%7C286f2b7d9113445bae51103e88d4584a%7C0%7C0%7C637340642734093968&sdata=L3c8zBZCq2JC7ED5awSMSwqSDfpsiUOSQP8zoya51V8%3D&reserved=0">www.pfizer.com</a>. In addition, to learn more, please visit us on <a href="https://nam01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcts.businesswire.com%2Fct%2FCT%3Fid%3Dsmartlink%26url%3Dhttp%253A%252F%252Fwww.pfizer.com%26esheet%3D52050497%26newsitemid%3D20190802005497%26lan%3Den-US%26anchor%3Dwww.pfizer.com%26index%3D5%26md5%3Df2d6fff8b59bbdcc3f649eefc44f5ece&data=02%7C01%7CTNigro%40ges.com%7C5f02348056af4fd247d808d849f0120f%7C286f2b7d9113445bae51103e88d4584a%7C0%7C0%7C637340642734103966&sdata=KsMY70LmgqkxrDZXRXWnsxooFHW7Xn4lGd7W%2BWJfwck%3D&reserved=0">www.pfizer.com</a> and follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.</p><p><a href="https://explorevyndamax.com/show/yiu34o/asnc-2020" target="_blank"><strong><span style="font-size: 30px;">Learn More About Vyndamax in Our Virtual Exhibit</span></strong></a></p><div class="embed-responsive embed-responsive-16by9"><div class="embed-responsive embed-responsive-16by9 embed-responsive-item" allowfullscreen="yes" scrolling="no"><br></div><p></p><div class="embed-responsive embed-responsive-16by9"><div class="embed-responsive embed-responsive-16by9 embed-responsive-item" allowfullscreen="yes" scrolling="no"><figure><iframe class="embed-responsive-item" allowfullscreen="yes" scrolling="no" src="//www.youtube.com/embed/Xl0tEfLve1U"></iframe></figure></div></div><p></p><div class="embed-responsive embed-responsive-16by9 embed-responsive-item" allowfullscreen="yes" scrolling="no"><br></div><div class="embed-responsive embed-responsive-16by9 embed-responsive-item" allowfullscreen="yes" scrolling="no"><figure><iframe class="embed-responsive-item" allowfullscreen="yes" scrolling="no" src="//www.youtube.com/embed/Xl0tEfLve1U"></iframe></figure></div></div><strong>Pfizer Inc.: Breakthroughs that change patients’ lives</strong><p></p><p>At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at <a href="https://nam01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcts.businesswire.com%2Fct%2FCT%3Fid%3Dsmartlink%26url%3Dhttp%253A%252F%252Fwww.pfizer.com%26esheet%3D52050497%26newsitemid%3D20190802005497%26lan%3Den-US%26anchor%3Dwww.pfizer.com%26index%3D4%26md5%3D3fa542ac15375f69f13286275e3e7339&data=02%7C01%7CTNigro%40ges.com%7C5f02348056af4fd247d808d849f0120f%7C286f2b7d9113445bae51103e88d4584a%7C0%7C0%7C637340642734093968&sdata=L3c8zBZCq2JC7ED5awSMSwqSDfpsiUOSQP8zoya51V8%3D&reserved=0">www.pfizer.com</a>. In addition, to learn more, please visit us on <a href="https://nam01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcts.businesswire.com%2Fct%2FCT%3Fid%3Dsmartlink%26url%3Dhttp%253A%252F%252Fwww.pfizer.com%26esheet%3D52050497%26newsitemid%3D20190802005497%26lan%3Den-US%26anchor%3Dwww.pfizer.com%26index%3D5%26md5%3Df2d6fff8b59bbdcc3f649eefc44f5ece&data=02%7C01%7CTNigro%40ges.com%7C5f02348056af4fd247d808d849f0120f%7C286f2b7d9113445bae51103e88d4584a%7C0%7C0%7C637340642734103966&sdata=KsMY70LmgqkxrDZXRXWnsxooFHW7Xn4lGd7W%2BWJfwck%3D&reserved=0">www.pfizer.com</a> and follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.</p></div></div><!--StartFragment--><!--StartFragment--><h1><br><br></h1>

<p>The IAEA serves as the world’s intergovernmental forum for scientific and technical cooperation in the nuclear field. It was set up as the world’s “Atoms for Peace” organization in 1957 within the United Nations family. The IAEA works with its Member States and multiple partners worldwide to promote safe, secure and peaceful nuclear technologies.</p><p>The IAEA is one of the leading publishers in the field of nuclear science and technology, and regularly issues books in the area of human health. Topics covered include, nuclear medicine, radiotherapy and nuclear imaging.</p><p><!--EndFragment--></p>

<p>We are pleased to unveil the new version of the <a href="https://www.siemens-healthineers.com/en-us/molecular-imaging/spect-and-spect-ct/c-cam" target="_blank">c.cam cardiac camera</a> at ASNC 2020! With low camera cost, low installation cost, and five years of warranty included, the c.cam has a low total cost of ownership and gives you the flexibility to scan patients quickly and conveniently. The high image quality and high throughput may allow you to increase the number of patients you are able to scan--improving your overall bottom line. <br></p><p></p><div class="embed-responsive embed-responsive-16by9"><figure><iframe src="https://players.brightcove.net/2744552178001/DQWzhzOOu_default/index.html?videoId=6193171365001" ;="" allowfullscreen="yes" allow="encrypted-media" style="position: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;" class="embed-responsive-item" scrolling="no"></iframe></figure></div><!--EndFragment--><p><strong><br></strong></p><p><strong>Augmented reality</strong>: See how the c.cam fits in your space! Scan the code with your Android or iOS device to view in AR.</p><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/309891dd8ecd77a16a9e9566fb8b5571.png" data-image="f8ez3mihriay" class="img-responsive" alt="custom image" title="custom image"><p><br></p><p><br></p><p>You can also learn more about our Symbia Intevo SPECT/CT family of scanners and the Biograph family of PET/CT scanners at our virtual booth.  </p><p><span style="font-size: 16px;"><span style="font-size: 18px;"><a href="https://www.siemens-healthineers.com/en-us/news-and-events/conferences-events-new/asnc" target="_blank"></a><a href="https://www.siemens-healthineers.com/en-us/news-and-events/conferences-events-new/asnc" target="_blank">Click here to explore our interactive virtual booth.</a><a href="https://www.siemens-healthineers.com/en-us/molecular-imaging/spect-and-spect-ct/c-cam" target="_blank"></a></span></span></p><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/7bf5d228b2c304856a599a4cb41e2201.jpg" data-image="rb8d57aywrpn" class="img-responsive" alt="custom image" title="custom image"><p><a href="https://www.siemens-healthineers.com/en-us/news-and-events/conferences-events-new/asnc#07487567_EN_US" target="_blank"><span style="font-size: 18px;">Contact us, request to speak to a representative, or schedule a virtual demo.</span></a></p><p>At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare.</p>

<p>Bracco Imaging offers products and solutions for all key diagnostic imaging modalities: X-ray (including Computed Tomography, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging, Contrast Enhanced Ultrasound, and Nuclear Medicine through radioactive tracers. This portfolio is complimented by a range of medical devices and advanced administration systems.<br></p><figure><a href="http://cardiogen.com/cardiac-pet/" target="_blank"><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/e736f92e9cc25b20992c9682ca6ffd44.jpg" data-image="o87j23h7gy4z" class="img-responsive" alt="custom image" title="custom image"></a></figure><p></p><div class="embed-responsive embed-responsive-16by9"><div class="embed-responsive embed-responsive-16by9 embed-responsive-item" allowfullscreen="yes" scrolling="no"><iframe class="embed-responsive-item" allowfullscreen="yes" scrolling="no" src="//www.youtube.com/embed/eV1Cpt72ZcY"></iframe></div></div><p></p><!--EndFragment-->

<p><span style="font-size: 24px;"><strong><span style="color: rgb(54, 96, 146);"><span style="color: rgb(79, 129, 189);"><span style="font-size: 30px;">Think <strong><span style="color: rgb(54, 96, 146);"><span style="color: rgb(79, 129, 189);"><span style="font-size: 30px;">N-13 </span></span></span></strong>Ammonia is beyond the budget and reach of your institution? <br>Think again.</span></span></span></strong></span></p><p><span style="font-size: 12px;"><span style="font-size: 18px;">IONETIX is pioneering a new approach to cardiac PET that makes offering superior imaging easy and affordable. Here’s how:</span></span></p><ul><li><span style="font-size: 12px;"><span style="font-size: 18px;"></span></span><span style="font-size: 12px;"><span style="font-size: 18px;">We put a small, powerful cyclotron near your imaging center – at <strong>no cost to you</strong>.</span></span></li><li><span style="font-size: 12px;"><span style="font-size: 18px;">We staff and operate the cyclotron and deliver up to 3 doses of N-13 Ammonia per hour.</span></span></li><li><span style="font-size: 12px;"><span style="font-size: 18px;">We provide marketing, clinical and reimbursement support </span><span style="font-size: 18px;"><span style="font-size: 18px;">as needed.</span></span></span></li><li><span style="font-size: 12px;"><span style="font-size: 18px;">You pay ONLY for the doses you order.</span></span></li><li><span style="font-size: 12px;"><span style="font-size: 18px;">You establish a brand-differentiating program that keeps patients close and drives referrals.<br><br></span></span></li></ul><p><span style="font-size: 20px;"><span style="font-size: 24px;"><span style="color: rgb(79, 129, 189);"><strong>Why <strong>N-13</strong> Ammonia  </strong><a href="https://www.ionetix.com/ammonia-n-13/" target="_blank"><span style="font-size: 18px;">click HERE</span></a></span></span></span> </p><p><span style="font-size: 16px;"><span style="font-size: 18px;">Now one of the mainstays of cardiac imaging, PET offers undeniably better imaging and diagnostic potential. When paired with N-13 Ammonia, the value of PET grows even clearer.</span></span></p><p><span style="font-size: 16px;"><span style="font-size: 18px;">With a low positron range and excellent extraction and retention, N-13 Ammonia paves the way to better imaging and diagnostics. The result is:</span></span></p><ul><li><span style="font-size: 16px;"><span style="font-size: 18px;">Superior imaging^1,2</span></span></li><li><span style="font-size: 16px;"><span style="font-size: 18px;">Enhanced diagnostics</span></span></li><li><span style="font-size: 16px;"><span style="font-size: 18px;">Better risk stratification and reclassification³</span></span></li><li><span style="font-size: 16px;"><span style="font-size: 18px;">Expanded test options<br></span></span></li></ul><img src="https://cdn1.digitellinc.com/uploads/asnc/directories/7/cdb17ee2351e67dcced66e5cf955fe89.jpg" data-image="egrbu1tfvwil" class="img-responsive" alt="custom image" title="custom image"><p><strong><span style="font-size: 24px; color: rgb(79, 129, 189);"><br></span></strong></p><p><strong><span style="font-size: 24px; color: rgb(79, 129, 189);">Why IONETIX </span></strong><a href="https://www.ionetix.com/company-overview/" target="_blank"><span style="font-size: 18px;">click HERE</span></a></p><p><span style="font-size: 18px;"><span style="font-size: 20px;">IONETIX has re-imagined and re-engineered the delivery model for N-13 Ammonia, making it affordable and achievable for practices of all sizes. </span></span></p><p><span style="font-size: 20px;"><span style="font-size: 18px;">Through our N-13 Ammonia as a service solution, we build, operate and promote revenue-generating cardiac PET programs using N-13 Ammonia as a tracer for health systems, hospitals, and cardiology and radiology practice groups. You get a </span><span style="font-size: 18px;">brand-differentiating cardiac PET program with ZERO capital outlay.</span><span style="font-size: 18px;"></span><span style="font-size: 18px;"></span><span style="font-size: 18px;"></span><span style="font-size: 18px;"><br> </span></span><strong><span style="font-size: 24px; color: rgb(79, 129, 189);"><br></span></strong><strong><span style="font-size: 24px; color: rgb(79, 129, 189);">Case Studies and Research</span></strong><span style="font-size: 18px;"> <a href="https://www.ionetix.com/research-peer-reviewed-papers/" target="_blank">click HERE</a></span></p><p><span style="font-size: 20px;"><span style="font-size: 18px;">IONETIX is committed to creating solutions that support and contribute to the science behind quality nuclear medicine. Click above to view case studies, white papers, and research on the efficacy and potential of N-13 Ammonia in cardiac PET.</span></span><span style="color: rgb(79, 129, 189);"><span style="font-size: 24px;"><br></span></span><span style="color: rgb(79, 129, 189);"><span style="font-size: 24px;"><span style="color: rgb(51, 51, 51); font-size: 18px;"></span><strong><br></strong></span></span><span style="color: rgb(79, 129, 189);"><span style="font-size: 24px;"><strong>See the IONETIX solution at work</strong></span><span style="font-size: 24px;"><span style="font-size: 18px;"> </span></span></span></p><p><span style="font-size: 18px;">To take a virtual tour of an IONETIX cyclotron installation, <a href="https://vimeo.com/452870375" target="_blank">click HERE</a></span></p><p><span style="font-size: 18px;"></span><span style="font-size: 18px;"></span><span style="font-size: 18px;"></span><span style="font-size: 18px;"></span><span style="color: rgb(183, 221, 232);"><span style="font-size: 18px;"></span><span style="font-size: 18px;"></span><span style="color: rgb(127, 127, 127);"><span style="color: rgb(149, 55, 52);"><span style="font-size: 24px;"><br></span></span></span></span><span style="font-size: 10px;"><span style="color: rgb(0, 0, 0);">^<br></span></span><span style="font-size: 10px;"><span style="color: rgb(0, 0, 0);">¹DOI: 10.2967/jnumed.111.101840<br></span></span><span style="font-size: 10px;"><span style="color: rgb(0, 0, 0);">²DOI: 10.1007/s00259-011-1877-y<br></span></span><span style="font-size: 10px;"><span style="color: rgb(0, 0, 0);">³DOI: 10.1161/CIRCULATIONAHA.111.050427 </span></span></p><p><span style="font-size: 20px;"><br></span></p><p></p>